Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.
about
Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases.Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.Non-parametric intravoxel incoherent motion analysis in patients with intracranial lesions: Test-retest reliability and correlation with arterial spin labeling.New Directions in Anti-Angiogenic Therapy for Glioblastoma.Bloch-Siegert B1-Mapping Improves Accuracy and Precision of Longitudinal Relaxation Measurements in the Breast at 3 T.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Differentiation between vasogenic edema and infiltrative tumor in patients with high-grade gliomas using texture patch-based analysis.Dynamic magnetic resonance imaging method based on golden-ratio cartesian sampling and compressed sensing.Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling.
P2860
Q31153877-73AD4756-13AA-46C3-8DC4-0996EC810BD7Q31158877-69AA9042-293A-4DD1-B2EB-9C0BF7F9B098Q35894329-7FA8F0F0-0840-4E04-88D4-271BC2497BA9Q37010827-C4420F5B-C9EE-469C-BF7A-8E8248547B27Q39022941-E40F257B-B71F-4BC7-AB15-3BC2AD3B6451Q39043712-75FF2BC9-06E7-4118-96F2-66B626D7D113Q43376098-8C8EE531-AA33-42B4-86DD-48DF53098A37Q47191350-0DC78000-5CCF-4A78-8386-D596F8A5B3EAQ47554817-48EE1987-2013-4E81-A882-8BE7C211A05DQ48225182-EEC28D52-1AC2-42C5-AC04-20E543C99135Q48541561-3927DA89-F132-498B-98C0-403F2F331C53Q55458839-D2E4562E-8791-4A57-A99C-0B3BA09A11C0
P2860
Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@en
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@nl
type
label
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@en
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@nl
prefLabel
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@en
Early biomarkers from dynamic ...... therapy in high-grade gliomas.
@nl
P2093
P2860
P50
P1433
P1476
Early biomarkers from dynamic ...... therapy in high-grade gliomas
@en
P2093
Alessandra Fabi
Anna Antenucci
Carmine Maria Carapella
P2860
P2888
P304
P356
10.1007/S00234-015-1582-9
P577
2015-09-12T00:00:00Z